Inflammation and Human Ovarian Follicular Dynamics

Abstract

Inflammation is a biologic process that mediates tissue effects including vasodilation, hyperemia, edema, collagenolysis, and cell proliferation through complex immunologic pathways. In regard to the ovary, inflammation has key physiologic roles in ovarian folliculogenesis and ovulation. On the other hand, inflammatory processes are subject to underlying pathology and, if pushed, proinflammatory conditions may have a negative impact on ovarian follicular dynamics. Obesity and polycystic ovary syndrome (PCOS) serve as examples of conditions associated with chronic endogenous production of low-grade proinflammatory cytokines. Both conditions negatively impact ovarian folliculogenesis and ovulation. The pages that follow summarize the role of inflammation in normal ovarian follicular dynamics and evidence for its role in mediating the negative effects of obesity and PCOS on ovarian follicular dynamics. The review concludes with a summary supporting a role for lifestyle factors that favorably impact inflammatory process involved in obesity and PCOS to improve ovarian function.

Keywords

inflammation - ovarian follicle - lifestyle - obesity - polycystic ovary syndrome

• References

• 1 Jungheim ES, Moley KH. Current knowledge of obesity's effects in the pre- and periconceptional periods and avenues for future research. Am J Obstet Gynecol 2010; 203 (6) 525-530
• 2 Fauser BC, Tarlatzis BC, Rebar RW , et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012; 97 (1) 28-38.e25
• 3 Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstet Gynecol 2007; 110 (5) 1050-1058
• 4 Asdell SA. The mechanism of ovulation. In: Zuckerman S, , ed. The Ovary. London: Academic Press; 1962: 435-449
• 5 Espey LL. Ovulation as an inflammatory reaction—a hypothesis. Biol Reprod 1980; 22 (1) 73-106
• 6 Espey LL. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 1994; 50 (2) 233-238
• 7 Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15 (2) 81-88
• 8 Clancy KB, Baerwald AR, Pierson RA. Systemic inflammation is associated with ovarian follicular dynamics during the human menstrual cycle. PLoS ONE 2013; 8 (5) e64807
• 9 Sarapik A, Velthut A, Haller-Kikkatalo K , et al. Follicular proinflammatory cytokines and chemokines as markers of IVF success. Clin Dev Immunol 2012; 2012: 606459
• 10 Büscher U, Chen FCK, Kentenich H, Schmiady H. Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction?. Hum Reprod 1999; 14 (1) 162-166
• 11 Priddy AR, Killick SR, Elstein M , et al. The effect of prostaglandin synthetase inhibitors on human preovulatory follicular fluid prostaglandin, thromboxane, and leukotriene concentrations. J Clin Endocrinol Metab 1990; 71 (1) 235-242
• 12 Pall M, Fridén BE, Brännström M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Hum Reprod 2001; 16 (7) 1323-1328
• 13 Smith G, Roberts R, Hall C, Nuki G. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs. Br J Rheumatol 1996; 35 (5) 458-462
• 14 Robker RL, Wu LL, Yang X. Inflammatory pathways linking obesity and ovarian dysfunction. J Reprod Immunol 2011; 88 (2) 142-148
• 15 Marquard KL, Stephens SM, Jungheim ES , et al. Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2011; 95 (6) 2146-2149 , 2149.e1
• 16 Shah DK, Missmer SA, Berry KF, Racowsky C, Ginsburg ES. Effect of obesity on oocyte and embryo quality in women undergoing in vitro fertilization. Obstet Gynecol 2011; 118 (1) 63-70
• 17 Luke B, Brown MB, Stern JE , et al. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod 2011; 26 (1) 245-252
• 18 Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med 2011; 29 (6) 507-513
• 19 Boots CE, Bernardi L, Stephenson MD. Does obesity increase the risk of euploid miscarriage in women with recurrent pregnancy loss?. Fertil Steril 2014; 102: 455-459
• 20 Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004; 19 (7) 1644-1646
• 21 Goldman KN, Hodes-Wertz B, McCulloh DH, Flom JD, Grifo JA. Association of body mass index with embryonic aneuploidy. Fertil Steril 2015; 103 (3) 744-748
• 22 Gu L, Liu H, Gu X, Boots C, Moley KH, Wang Q. Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes. Cell Mol Life Sci 2015; 72 (2) 251-271
• 23 Wu LL, Norman RJ, Robker RL. The impact of obesity on oocytes: evidence for lipotoxicity mechanisms. Reprod Fertil Dev 2011; 24 (1) 29-34
• 24 Luzzo KM, Wang Q, Purcell SH , et al. High fat diet induced developmental defects in the mouse: oocyte meiotic aneuploidy and fetal growth retardation/brain defects. PLoS ONE 2012; 7 (11) e49217
• 25 Carman GM. Thematic minireview series on the lipid droplet, a dynamic organelle of biomedical and commercial importance. J Biol Chem 2012; 287 (4) 2272
• 26 Shkolnik K, Tadmor A, Ben-Dor S, Nevo N, Galiani D, Dekel N. Reactive oxygen species are indispensable in ovulation. Proc Natl Acad Sci U S A 2011; 108 (4) 1462-1467
• 27 Gesink Law DC, Maclehose RF, Longnecker MP. Obesity and time to pregnancy. Hum Reprod 2007; 22 (2) 414-420
• 28 Fabbrini E, Yoshino J, Yoshino M , et al. Metabolically normal obese people are protected from adverse effects following weight gain. J Clin Invest 2015; 125 (2) 787-795
• 29 Wildman RP, Muntner P, Reynolds K , et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008; 168 (15) 1617-1624
• 30 Wildman RP, Kaplan R, Manson JE , et al. Body size phenotypes and inflammation in the Women's Health Initiative Observational Study. Obesity (Silver Spring) 2011; 19 (7) 1482-1491
• 31 Duleba AJ, Dokras A. Is PCOS an inflammatory process?. Fertil Steril 2012; 97 (1) 7-12
• 32 Schmidt J, Weijdegård B, Mikkelsen AL, Lindenberg S, Nilsson L, Brännström M. Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women. Mol Hum Reprod 2014; 20 (1) 49-58
• 33 Hasegawa T, Negishi T, Deguchi M. WBC count, atherosclerosis and coronary risk factors. J Atheroscler Thromb 2002; 9 (5) 219-223
• 34 Herlihy AC, Kelly RE, Hogan JL, O'Connor N, Farah N, Turner MJ. Polycystic ovary syndrome and the peripheral blood white cell count. J Obstet Gynaecol 2011; 31 (3) 242-244
• 35 Orio Jr F, Palomba S, Cascella T , et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90 (1) 2-5
• 36 Hurwitz A, Payne DW, Packman JN , et al. Cytokine-mediated regulation of ovarian function: interleukin-1 inhibits gonadotropin-induced androgen biosynthesis. Endocrinology 1991; 129 (3) 1250-1256
• 37 Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011; 95 (3) 1048-58.e1 , 2
• 38 Kelly CCJ, Lyall H, Petrie JR, Gould GW, Connell JMC, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001; 86 (6) 2453-2455
• 39 Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007; 49 (21) 2129-2138
• 40 Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003; 80 (1) 123-127
• 41 Blair SA, Kyaw-Tun T, Young IS, Phelan NA, Gibney J, McEneny J. Oxidative stress and inflammation in lean and obese subjects with polycystic ovary syndrome. J Reprod Med 2013; 58 (3–4) 107-114
• 42 González F, Nair KS, Daniels JK, Basal E, Schimke JM. Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women. Am J Physiol Endocrinol Metab 2012; 302 (3) E297-E306
• 43 Morin-Papunen L, Rantala AS, Unkila-Kallio L , et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab 2012; 97 (5) 1492-1500
• 44 Dunning KR, Russell DL, Robker RL. Lipids and oocyte developmental competence: the role of fatty acids and β-oxidation. Reproduction 2014; 148 (1) R15-R27
• 45 Dumesic DA, Meldrum DR, Katz-Jaffe MG, Krisher RL, Schoolcraft WB. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril 2015; 103 (2) 303-316
• 46 Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011; 60 (10) 2441-2449
• 47 Holte J, Bergh T, Berne C, Lithell H. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf) 1994; 41 (4) 463-471
• 48 Jungheim ES, Macones GA, Odem RR , et al. Associations between free fatty acids, cumulus oocyte complex morphology and ovarian function during in vitro fertilization. Fertil Steril 2011; 95 (6) 1970-1974
• 49 Jungheim ES, Frolova AI, Jiang H, Riley JK. Relationship between serum polyunsaturated fatty acids and pregnancy in women undergoing in vitro fertilization. J Clin Endocrinol Metab 2013; 98 (8) E1364-E1368
• 50 Wakefield SL, Lane M, Schulz SJ, Hebart ML, Thompson JG, Mitchell M. Maternal supply of omega-3 polyunsaturated fatty acids alter mechanisms involved in oocyte and early embryo development in the mouse. Am J Physiol Endocrinol Metab 2008; 294 (2) E425-E434
• 51 Rich-Edwards JW, Spiegelman D, Garland M , et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology 2002; 13 (2) 184-190
• 52 Giallauria F, Palomba S, Maresca L , et al. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2008; 69 (5) 792-798
• 53 Covington JD, Tam CS, Pasarica M, Redman LM. Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise. Biochimie 2014; ; Epub ahead of print